Wall Street is on a roller coaster again, as investors try to navigate the path between high inflation and the Fed’s aggressive interest rate hikes. The former is raging – whether you blame Russia or Biden, the fact of high inflation can no longer be avoided – while the latter is rising – but whether it is rising fast enough to blunt inflation is yet to be determined. Jim Cramer, the well-known host of CNBC’s ‘Mad Money’ program, takes a hint from the bond market, where the US Treasury 2-year no
Shares of Biogen (NASDAQ: BIIB) were skyrocketing 36% as of 11:10 a.m. ET on Wednesday. The huge gain came after the company and its partner Eisai (OTC: ESALY) announced positive results on Tuesday from their late-stage Clarity AD study evaluating lecanemab in treating Alzheimer's disease. The news also propelled two stocks of other drugmakers developing Alzheimer's disease drugs significantly higher.
Dividends can offer fat full-time income. But the math needs to work.
Baird Senior Research Analyst Brian Skorney joins Yahoo Finance Live to discuss the breakthrough of Biogen's Alzheimer's drug, which is pushing the stock higher.
Creating income for retirement is one of the biggest challenges American workers have in planning for how they will be able to live comfortably once they stop working. One of the most common ways to create this income is to … Continue reading → The post If You Have This Much Money Saved You Don't Need an Annuity appeared first on SmartAsset Blog.
General Motors CEO Mary Barra yesterday apologized to salaried workers for the timing of a memo sent late Friday afternoon outlining a new back-to-office policy and delayed the implementation of the plan. The email said that GM employees who had been working remotely during the pandemic would be required later this year to return to the office at least three days a week, the Detroit Free Press reported. The email triggered employee pushback about both the updated policy and the timing of the announcement, leading Barra to partially walk back the decision, announcing Tuesday that the automaker will not implement the requirement this year but that “a more regular, in-person presence” will still be the plan for the future.
The current cap on yearly buys of I bonds is $10,000 per person plus $5,000 through federal tax refunds. Two senators propose raising that limit to $30,000 in total.
The Dow Jones Industrial Average rose Wednesday, ahead of Fed chief Powell's speech, struggling to avoid a seventh straight decline.
Top trending stocks in after hours trading on Wednesday, September 28, 2022.
Analysts are either optimistic or delusional. But either way, they see a big S&P 500 29% rally coming — and have picked favorite stocks.
Biogen stock rips higher on a promising new drug. Here's what Wall Street is saying.
Shares of Nano-X Imaging (NASDAQ: NNOX), commonly called Nanox, soared on Wednesday after it revealed it's taken the next step toward commercializing its flagship medical device. As of 12:20 p.m. ET, Nanox stock was up 21%. Nanox had its initial public offering (IPO) in 2020, promising to disrupt the X-ray industry with its digital-3D imaging machines that will be cheaper for doctors to use.
While the I bond yield is expected to moderate, it still remains extremely attractive as a risk-free investment.
The super investor isn't thrilled with the Fed. But she's still bullish.
In this article, we discuss 11 best dividend-paying stocks to buy now. You can skip our detailed analysis of dividend stocks and their returns, and go directly to read 5 Best Dividend Paying Stocks To Buy Now. Dividend companies are gaining ground among investors this year as they navigate the rocky market. In times of financial […]
Anyone following stock market trends in 2022 will be well aware of the widespread drawbacks; apart from some outliers such as energy, most corners of the market have been beaten to a pulp. The main culprits are easily identified by now; a combination of a slowing economy, rampant inflation, rates hikes to halt it, and Russia’s invasion of Ukraine and the global implications are all responsible factors. Stock market giants have not been immune either and many have seen huge chunks of their valuat
Shares of beaten-down big tech stocks Nvidia (NASDAQ: NVDA), Meta Platforms (NASDAQ: META), and Palantir Technologies (NYSE: PLTR) bounced back today, rising 2%, 3.4%, and 2.8%, respectively, as of 11:34 a.m. ET. There wasn't much company specific news from these three today, but their shares being down so much on the year already, combined with some marginally favorable news this morning on interest rates and geopolitics, was enough to get their stocks moving higher. Equity investors may not have noticed, but Treasury Bond yields may be determining your stock portfolio performance this year more than you think -- especially when it comes to technology growth stocks.
Marijuana stocks continued to rebound from last week's sell-off on Wednesday, with shares of Canopy Growth (NASDAQ: CGC) gaining 4.2%, Tilray Brands (NASDAQ: TLRY) up 4.8%, and Aurora Cannabis (NASDAQ: ACB) leading the whole pack higher with a 5.4% gain as of 1:40 p.m. ET. The Nasdaq -- to which index all three of these cannabis stocks belong -- is up 1.5% in midafternoon trading. This morning, Canopy announced that in an effort to progress from losses toward profitability, it will divest its Canadian Tweed and Tokyo Smoke retail operations and focus in the future on producing "premium" branded cannabis as a consumer packaged goods company.
Yahoo Finance Live checks out Netflix's shares after Atlantic Equities upgrades the company's stock to "Neutral" and the streaming platform announces plans to limit password sharing.
The stock market doesn't care what your cost basis is. NVIDIA (NASDAQ: NVDA) and Advanced Micro Devices (NASDAQ: AMD), two semiconductor stocks that were soaring until late 2021, have seen much of those gains come undone as chip shortages have given way to chip gluts. Both NVIDIA and AMD were doing well before the pandemic hit.